- Home
- XRTX vs JNVR Comparison
XRTX vs JNVR Comparison
Compare XRTX & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- JNVR
- Stock Information
- Founded
- XRTX 2011
- JNVR 2018
- Country
- XRTX Canada
- JNVR United States
- Employees
- XRTX N/A
- JNVR N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- JNVR Finance: Consumer Services
- Sector
- XRTX Health Care
- JNVR Finance
- Exchange
- XRTX Nasdaq
- JNVR Nasdaq
- Market Cap
- XRTX 5.0M
- JNVR 5.1M
- IPO Year
- XRTX N/A
- JNVR 2023
- Fundamental
- Price
- XRTX $1.33
- JNVR $0.53
- Analyst Decision
- XRTX Strong Buy
- JNVR
- Analyst Count
- XRTX 1
- JNVR 0
- Target Price
- XRTX $14.00
- JNVR N/A
- AVG Volume (30 Days)
- XRTX 22.7K
- JNVR 1.3M
- Earning Date
- XRTX 11-29-2024
- JNVR 11-06-2024
- Dividend Yield
- XRTX N/A
- JNVR N/A
- EPS Growth
- XRTX N/A
- JNVR N/A
- EPS
- XRTX N/A
- JNVR N/A
- Revenue
- XRTX N/A
- JNVR $1,820,969.00
- Revenue This Year
- XRTX N/A
- JNVR N/A
- Revenue Next Year
- XRTX N/A
- JNVR N/A
- P/E Ratio
- XRTX N/A
- JNVR N/A
- Revenue Growth
- XRTX N/A
- JNVR N/A
- 52 Week Low
- XRTX $1.09
- JNVR $0.42
- 52 Week High
- XRTX $7.00
- JNVR $1.84
- Technical
- Relative Strength Index (RSI)
- XRTX 41.92
- JNVR 45.70
- Support Level
- XRTX $1.29
- JNVR $0.43
- Resistance Level
- XRTX $1.42
- JNVR $0.69
- Average True Range (ATR)
- XRTX 0.15
- JNVR 0.09
- MACD
- XRTX -0.01
- JNVR 0.00
- Stochastic Oscillator
- XRTX 18.75
- JNVR 41.21
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.